Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03889561 · ClinicalTrials.gov registry record · NA
Evaluation of the Impact of Water Access and Promotion in Parks on Beverage Intake
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 1,038
- Enrollment target
NCT03889561: Completed NA study, sponsored by Stanford University.
NCT03889561 is a NA study that has completed, run by Stanford University. The registered enrollment target is 1,038 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (26% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03889561, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,038 participants
- Enrollment target
Study Summary
Sugar-sweetened beverages (SSBs) are a major caloric source and the largest source of added sugars in the American diet. While many cities around the country have adopted anti-SSB policies such as soda taxes to reduce SSB intake, there has yet to be any studies to evaluate if the effects of these taxes, coupled with increased water access and promotion effort can lead to decreased sugar sweetened beverage consumption and increased water consumption. This quasi-experimental study evaluates how implementation of SSB taxes, installation of new water stations, and a multicultural water promotion campaign in parks impacts beverage intake in these settings as compared to soda taxes alone.
Primary Outcome
Changes in beverage consumption will be measured through site observations to tally the proportion of visitors drinking water and SSBs in parks.
Interventions
- BEHAVIORAL Drink Tap
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,038 participants |
| Start Date | 2016-04-15 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
What the finished NCT03889561 record still lists
NCT03889561 is an interventional study that assigns participants to a tested intervention. Its 1,038 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (26% lower).
The record links to 0 conditions, and to 1 intervention - of which Drink Tap is the first listed.
NCT03889561 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03889561 about?
NCT03889561 is a clinical study titled "Evaluation of the Impact of Water Access and Promotion in Parks on Beverage Intake". Sugar-sweetened beverages (SSBs) are a major caloric source and the largest source of added sugars in the American diet. While many cities around the country have adopted anti-SSB policies such as soda taxes to reduce SSB intake, there has yet to be any studies to evaluate if the effects of these ta...
What is the current status of trial NCT03889561?
This trial is currently completed. It is a NA study. The enrollment target is 1,038 participants. The study started on 2016-04-15. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03889561?
The interventions under investigation include: Drink Tap (BEHAVIORAL).
Who is sponsoring clinical trial NCT03889561?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03889561's enrollment target sits among peer trials
1,038 101st of 2000 higher than 1,899 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07345767 · 1,038 participants · NA
Hypknowledge Nationwide Sleep Extension
- NCT05219110 · 1,040 participants · NA
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
- NCT06564948 · 1,040 participants · NA
Treatment for Individuals Interacting with the Criminal Justice System
- NCT06661720 · 1,040 participants · Phase 3
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI